Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$57.33 - $68.61 $1.39 Million - $1.66 Million
-24,218 Reduced 20.41%
94,418 $6.24 Million
Q1 2024

May 10, 2024

SELL
$56.55 - $66.59 $1.11 Million - $1.31 Million
-19,669 Reduced 14.22%
118,636 $6.76 Million
Q3 2023

Nov 08, 2023

BUY
$57.77 - $65.93 $1.78 Million - $2.03 Million
30,736 Added 28.57%
138,305 $7.99 Million
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $6.56 Million - $8.12 Million
107,569 New
107,569 $6.7 Million
Q2 2020

Aug 05, 2020

SELL
$74.18 - $108.93 $250,431 - $367,747
-3,376 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$63.18 - $85.97 $284,057 - $386,521
-4,496 Reduced 57.11%
3,376 $247,000
Q3 2019

Nov 06, 2019

BUY
$72.82 - $86.52 $110,686 - $131,510
1,520 Added 23.93%
7,872 $584,000
Q2 2019

Aug 07, 2019

SELL
$73.52 - $88.7 $9 Million - $10.9 Million
-122,377 Reduced 95.07%
6,352 $540,000
Q1 2019

May 13, 2019

SELL
$63.56 - $88.17 $8.31 Million - $11.5 Million
-130,809 Reduced 50.4%
128,729 $11.1 Million
Q4 2018

Feb 12, 2019

BUY
$58.5 - $69.94 $3.58 Million - $4.28 Million
61,200 Added 30.86%
259,538 $16.5 Million
Q3 2018

Nov 13, 2018

BUY
$61.75 - $74.23 $9.25 Million - $11.1 Million
149,838 Added 308.94%
198,338 $13.7 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $8.42 Million - $10.5 Million
-90,000 Reduced 64.98%
48,500 $4.59 Million
Q3 2017

Nov 13, 2017

BUY
$109.15 - $138.27 $15.1 Million - $19.2 Million
138,500
138,500 $16.2 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.